The 2024 Rising Stars in Malignant Hematology Conference will serve a foundational role in helping early-in-practice hematologists gain meaningful insight into patient and disease management for hematologic malignancies. This event is geared towards the early-in-practice clinician and will include didactic lectures, complex case discussions, and panel Q&A sessions.
Scientific Steering Committee
The scientific steering committee for the 2024 Rising Stars in Malignant Hematology Conference includes Dr. Peter Anglin and Dr. Alissa Visram.
Alissa Visram, MD
Peter Anglin, MD
Register Today: Spots Are Limited!
Only 40 spots, including limited travel grants, are available for this one-of-a-kind conferenceand we encourage you to register early.
If you are able to join us, kindly RSVP by registering to the conference using the link below. Registrations will close on August 31st, 2024, or when the conference reaches capacity. As space is limited, we encourage you to RSVP at your earliest convenience if you plan to attend.
The 2024 Rising Stars in Malignant Hematology Conference will serve a foundational role in helping early-in-practice hematologists gain meaningful insight into patient and disease management for hematologic malignancies.
Time
Topic
Speaker
9:00 am - 9:10 am
Welcome and Introductions
Alissa Visram
9:10 am - 9:45 am
Personalized Medicine:
Understanding the Genetic and
Molecular Characteristics of CLL and
Tailoring Treatment
(Sponsored Breakfast Symposium
AstraZeneca Canada)
Philip Kuruvilla
9:45 am - 10:20 am
Approaches to MM: Novel Agents in a
Relapse Setting
Darrell White
10:20 am - 10:55 am
Management of AML in 2024: Frontline Therapy
Julie Bergeron
10:55 am - 11:15 am
HEALTH BREAK
ALI
11:15 am - 11:50 am
Updates on the Management of MPN: Current Agents and Approaches to Treatment in First and 2nd Line Therapies
Vikas Gupta
11:50 am - 1:00 pm
CHECKOUT & LUNCH
ALL
1:00 pm - 1:35 pm
Updates on the Management of CLL : Current Agents and Approaches to Treatment in a Relapse Setting
Mona Shafey
1:35 pm - 2:10 pm
Updates on the Management of FL
and Aggressive B-cell Lymphoma:
Current Agents and Approaches to
Treatment in a Relapse Setting
John Kuruvilla
2:10 pm - 2:45 pm
Important Tips & Pearls:
Reimbursement, Compassionate
Use, Access, Path to Approval,
Patient Support Program, Resources
for Patients
Darrell White
2:45 pm - 3:20 pm
Attendee Q&A for Conference Faculty
ALL
3:20 pm - 3:30 pm
Meeting Close & Adjournment
Peter Anglin
Subscribe To Canadian Hematology Today
Canadian Hematology Today provides a forum for the clinical community to share real-world experience and the latest best practices in the treatment and management of hematologic disease.
The journal is published thrice yearly in English and French and is circulated to over 1,100 hematology clinicians and researchers across Canada. It features peer-reviewed articles that present robust clinical perspectives and practical insights into disease management.
Founded in 2009, Catalytic Health is one of Canada’s largest medical education agencies and reaches over 50,000 Canadian clinicians a year with its educational programs, services and platforms. Catalytic Health is also the largest independent medical publisher in Canada, one of the largest scientific conference providers, and a leader in innovative events and services for the Life Sciences industry. Learn more about Catalytic Health.